Document is current
Any future updates will be listed below
-
Authors
Zhu, Biying
He, Na
Xiao, Yang https://orcid.org/0000-0002-9297-0973
Chen, Bin
Li, Chen
Mandla, Ravi https://orcid.org/0000-0002-0782-0138
Liu, Yifan
Zhang, Jiayu
Chang, Xiao
Yu, Fulong https://orcid.org/0000-0002-6100-8300
Vujkovic, Marijana https://orcid.org/0000-0003-4924-5714
Lynch, Julie A. https://orcid.org/0000-0003-0108-2127
Chang, Kyong-Mi https://orcid.org/0000-0001-6811-9364
,
Pasaniuc, Bogdan https://orcid.org/0000-0002-0227-2056
Rader, Daniel J. https://orcid.org/0000-0002-9245-9876
Lazar, Mitchell A. https://orcid.org/0000-0001-8653-1280
Hu, Wenxiang https://orcid.org/0000-0002-6754-5625
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 28 April 2026
First Online: 2 June 2026
Competing interests
: M.A.L. is on a scientific advisory board of Pfizer and is co-founder and serves on the scientific advisory board of Flare Therapeutics. D.J.R. is on the scientific advisory board for Alnylam, Novartis and Verve. The remaining authors declare no competing interests.
